Abstract
These experiments demonstrate that the cholestasis following manganese-bilirubin administration varies directly in severity in relation to the amount of bilirubin administered. This suggests that the cholestasis is related to critical bilirubin accumulation in some compartment of the biliary excretory pathway. However, in the immediate precholestatic period, the levels of bilirubin in all three compartments of blood, liver and bile also vary in direct relation to the amount of bilirubin administered. The critical site of bilirubin accumulation or concentration is not, therefore, defined by these experiments.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HARGREAVES T. THE ESTIMATION OF BILIRUBIN IN LIVER. Clin Chim Acta. 1965 Mar;11:278–280. doi: 10.1016/0009-8981(65)90075-6. [DOI] [PubMed] [Google Scholar]
- Roberts R. J., Plaa G. L. Alteration of the plasma disappearance and biliary excretion patterns of exogenously administered bilirubin by alpha-nephthylisothiocyanate. J Pharmacol Exp Ther. 1967 Feb;115(2):330–336. [PubMed] [Google Scholar]
- Witzleben C. L. Bilirubin as a cholestatic agent. Physiologic and morphologic observations. Am J Pathol. 1971 Feb;62(2):181–194. [PMC free article] [PubMed] [Google Scholar]
- Witzleben C. L. Physiologic and morphologic natural history of a model of intrahepatic cholestasis (manganese-bilirubin overload). Am J Pathol. 1972 Mar;66(3):577–588. [PMC free article] [PubMed] [Google Scholar]